Chlorambucil--still not bad: a reappraisal. (Record no. 21266662)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01279 a2200325 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516062316.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201205s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 2152-2669 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/j.clml.2011.02.006 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Catovsky, Daniel |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20120517 |
245 00 - TITLE STATEMENT | |
Title | Chlorambucil--still not bad: a reappraisal. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Clinical lymphoma, myeloma & leukemia |
Date of publication, distribution, etc. | Jun 2011 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | S2-6 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Chlorambucil |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Clinical Trials, Phase II as Topic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Clinical Trials, Phase III as Topic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease-Free Survival |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Leukemia, Lymphocytic, Chronic, B-Cell |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Randomized Controlled Trials as Topic |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Else, Monica |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Richards, Sue |
773 0# - HOST ITEM ENTRY | |
Title | Clinical lymphoma, myeloma & leukemia |
Related parts | vol. 11 Suppl 1 |
-- | p. S2-6 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.clml.2011.02.006">https://doi.org/10.1016/j.clml.2011.02.006</a> |
Public note | Available from publisher's website |
No items available.